View Older Stories View More Recent Stories
-
Nektar Therapeutics Prices Public Offering of Shares of Common Stock
-
Janney Montgomery Scott Downgrades USD Partners LP (USDP) to Neutral
-
Janney Montgomery Scott Starts Hospitality Properties Trust (HPT) at Buy
-
Great Elm Capital Group Commences Rights Offering
-
Landmark Infrastructure Partners (LMRK) Prices 3M Common Units Offering for Proceeds of ~$48.9M
-
Landmark Infrastructure Partners LP Announces Pricing of Public Offering of Common Units
-
Depomed (DEPO): September Rx Data Increases Confidence - Janney
-
Ashford Trust Prices Public Offering Of Preferred Stock
-
Landmark Infrastructure Partners (LMRK) to Offer 3M Common Units
-
Landmark Infrastructure Partners LP Announces Launch of Public Offering of Common Units
-
Bluerock Residential Growth REIT (BRG) Announces Closing of Public Offering of Series D Preferred Stock
-
Janney Montgomery Scott Downgrades Endurance Specialty Holdings (ENH) to Neutral
-
Janney Montgomery Scott Downgrades Illumina (ILMN) to Sell
-
Depomed (DEPO): Symphony Data Underreporting An Issue But Not Material - Janney
-
Janney Spreads Across Connecticut, Adds Five Advisors From Merrill Lynch
-
Form MA/A JANNEY MONTGOMERY SCOTT
-
Bluerock Residential Growth REIT (BRG) Prices Series D Preferred Stock Offering
-
Bluerock Residential Growth REIT (BRG) Announces Public Offering of Series D Cumulative Preferred Stock
-
Janney Montgomery Scott Reiterates Buy as Court Rules in Favor of Depomed (DEPO)
-
Janney Montgomery Scott Upgrades First Cash Financial (FCFS) to Buy
-
Quovo Unveils Advisor Dashboard, Arming Financial Advisors With Enriched Client Data Insights in an Intuitive User Interface
-
FBR Announces Addition of Stephen Moss to Equity Research Team
-
Depomed (DEPO): Handicapping The District Court Ruling Impact - Janney
-
Janney Montgomery Scott Starts Boardwalk Pipeline Partners (BWP) at Neutral
-
Janney Montgomery Scott Starts Ionis Pharmaceuticals (IONS) at Buy
-
Janney Montgomery Scott Starts Intellia Therapeutics (NTLA) at Buy
-
Janney Montgomery Scott Starts ProQR Therapeutics N.V. (PRQR) at Neutral
-
Janney Montgomery Scott Starts Alnylam Pharmaceuticals (ALNY) at Neutral
-
Janney Sees Potential DepoMed (DEPO) Court Decision Delay
-
Vail Resorts (MTN): Whistler Acquisition Is Next EBITDA Stepup In '17 - Janney
-
City Office REIT, Inc. Announces Pricing of 6.625% Series A Preferred Stock Offering
-
Gladstone Investment Corporation Announces Closing of Offering of 2,300,000 Shares of its 6.25% Series D Cumulative Term Preferred Stock for Gross Proceeds of Approximately $57.5 million
-
Notable Analyst Rating Changes 9/26: (DBD) (ETE) (ANDE) Upgraded; (DRH) (NTAP) (LYG) Downgraded
-
Brandon Eck joins Mufson Howe Hunter as a Managing Director & Head of Technology Services
-
Janney Montgomery Scott Upgrades Applied Genetic Technologies Corp. (AGTC) to Neutral
-
Janney Montgomery Scott Starts RLJ Lodging Trust (RLJ) at Buy
-
Janney Montgomery Scott Starts Felcor Lodging Trust (FCH) at Buy
-
Pre-Open Stock Movers 09/23: (MIFI) (BATS) (TWTR) Higher; (ENPH) (IPCI) (APRI) Lower (more...)
-
Janney Montgomery Scott Upgrades BioDelivery Sciences International (BDSI) to Buy
-
Janney Montgomery Scott Upgrades CSI Compressco LP (CCLP) to Buy
-
Chesapeake Utilities (CPK) Prices 835.2k Stock Offering at $62.26/Share
-
Chesapeake Utilities Corporation Prices Public Offering of Common Stock
-
Chesapeake Utilities (CPK) Announces $52M Common Stock Offering
-
Chesapeake Utilities Corporation Announces Common Stock Offering
-
Janney Montgomery Scott Downgrades Clovis Oncology (CLVS) to Neutral
-
Janney Montgomery Scott Starts Golub Capital BDC (GBDC) at Neutral
-
Gladstone Investment Corporation Prices Preferred Stock Offering
-
Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
-
Gladstone Investment Corporation Launches New Term Preferred Stock Offering
-
Janney Montgomery Scott Starts Watts Waters (WTS) at Neutral
